Additional file 3: Table S3. List of clinical trials with non-engineered combination NK cell therapies. N = 62 clinical trials (Phase I, II, or I/II) evaluating the infusion of non-engineered allogene
Natural killer (NK) cells are innate cytotoxic lymphocytes that play an important role in surveillance and elimination of cancer. Allogeneic NK cell adoptive transfer has shown the potential to induce
Adoptive transfer of natural killer (NK) cells can induce remission in patients with relapsed/refractory leukemia and myeloma. However, to date, clinical efficacy of NK cell immunotherapy has been lim